Chao‐Nan Qian
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 9
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
-
- Lung Cancer Diagnosis and Treatment 4
- Radiation Therapy and Dosimetry 4
- Renal cell carcinoma treatment 3
- Hepatology top 10%
-
- Advanced Radiotherapy Techniques 5
-
- Fibroblast Growth Factor Research 3
- Angiogenesis and VEGF in Cancer 3
- Co-authors
- Bin Tean TehMing‐Huang HongBill WondergemDan HuangXiang GuoQiuyan ChenKa–Jia CaoHua-Qing Min
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (3 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Chao‐Nan Qian
31 papers receiving 804 citations
Peers
Comparison fields: 5 of 72
- Otorhinolaryngology 320
- Oncology 309
- Cancer Research 146
- Pulmonary and Respiratory Medicine 276
- Hepatology 61
Countries citing papers authored by Chao‐Nan Qian
This map shows the geographic impact of Chao‐Nan Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao‐Nan Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao‐Nan Qian more than expected).
Fields of papers citing papers by Chao‐Nan Qian
This network shows the impact of papers produced by Chao‐Nan Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao‐Nan Qian. The network helps show where Chao‐Nan Qian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chao‐Nan Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 29 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 18 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 2 | |
| 9 | Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports | 2020 | 1 |
| 10 | 2020 | 17 | |
| 11 | 2020 | 3 | |
| 12 | 2019 | 18 | |
| 13 | 2016 | 45 | |
| 14 | 2015 | 30 | |
| 15 | 2014 | 33 | |
| 16 | 2011 | 39 | |
| 17 | 2010 | 1 | |
| 18 | 2009 | 107 | |
| 19 | 2009 | 94 | |
| 20 | 2000 | 5 |
About Chao‐Nan Qian
Chao‐Nan Qian is a scholar working on Otorhinolaryngology, Radiation and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 812 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (9 papers), Advanced Radiotherapy Techniques (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Radiation Therapy and Dosimetry (4 papers), Fibroblast Growth Factor Research (3 papers), Renal cell carcinoma treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Otorhinolaryngology (320 citations), Oncology (309 citations) and Cancer Research (146 citations). Chao‐Nan Qian has collaborated with scholars based in China, United States and France. Frequent co-authors include Bin Tean Teh, Ming‐Huang Hong, Bill Wondergem, Dan Huang, Xiang Guo, Qiuyan Chen, Ming‐Huang Hong, Ka–Jia Cao, Hua-Qing Min and Yi‐Jun Hua. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.